ποΈποΈ ICD-10-CM Code H16.013 β Central Corneal Ulcer, Bilateral
Quick Reference
Code Type: ICD-10-CM Diagnosis | HCC (v28): β No | Laterality Subcode: β Bilateral β both eyes involved simultaneously | MS-DRG: 121 / 122 β Acute Major Eye Infections | MDC: 02 β Diseases and Disorders of the Eye | Clinical Flag: Bilateral central corneal ulcers are rare and should trigger systemic workup
π Clinical Description
ICD-10-CM H16.013 β central corneal ulcer, bilateral β describes full-thickness epithelial defects with underlying stromal loss located at the central optical zone of both corneas simultaneously. Bilateral central corneal ulceration is an uncommon presentation that carries greater clinical urgency than its unilateral counterparts: not only does it threaten vision in both eyes, but its simultaneous bilateral nature is a significant clinical red flag that demands investigation of an underlying systemic, immunosuppressive, or autoimmune etiology. A healthy patient with two intact immune systems and intact corneal surfaces rarely develops bilateral central corneal ulcers from isolated local insult alone.
The pathophysiology mirrors unilateral central corneal ulceration β disruption of the corneal epithelial barrier permits invasion by bacterial, viral, fungal, or amoebic pathogens at the most visually critical zone β but the bilateral simultaneous occurrence points toward systemic predisposing factors: HIV/AIDS with profound immunosuppression, bilateral contact lens wear with contaminated lens solution (particularly Acanthamoeba), autoimmune conditions such as rheumatoid arthritis or systemic lupus erythematosus triggering peripheral ulcerative keratitis or Mooren-like bilateral involvement, severe bilateral lagophthalmos (as in bilateral facial palsy or thyroid eye disease with severe proptosis), Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) causing bilateral corneal surface destruction, or bilateral chemical injury. Without prompt, aggressive topical and often systemic treatment, bilateral stromal keratolysis can progress to bilateral corneal perforation, representing a catastrophic ophthalmologic emergency.
The clinical course follows three recognizable phases in both eyes:
- Acute/Active phase β bilateral epithelial defects with stromal infiltrate on slit-lamp exam with fluorescein; severe bilateral pain, photophobia, tearing, conjunctival injection, and reduced vision in both eyes; hypopyon may be present unilaterally or bilaterally depending on severity and organism
- Treatment phase β intensive topical antimicrobial therapy to both eyes; systemic treatment added when fungal, viral, or systemic autoimmune etiology is identified; systemic workup initiated to identify or confirm underlying predisposing condition
- Resolution/Scarring phase β re-epithelialization with residual bilateral stromal haze or leukoma; bilateral visual acuity outcomes depend on scar density, depth, and optical zone involvement; bilateral penetrating keratoplasty may be required and carries significant rehabilitation complexity
π¬ Clinical Features & Diagnostic Considerations
| Feature | Bilateral Central Corneal Ulcer (H16.013) | Unilateral Central Corneal Ulcer (H16.011 / H16.012) | Bilateral Marginal Corneal Ulcer (H16.043) |
|---|---|---|---|
| Laterality | Both eyes, central zone | One eye, central zone | Both eyes, peripheral/limbal zone |
| Systemic red flag | β High β bilateral = investigate systemically | Lower β often local/contact lens etiology | Moderate β may indicate autoimmune (RA, rosacea) |
| Common etiology | HIV, bilateral CL wear, SJS/TEN, autoimmune, bilateral lagophthalmos | Bacterial (contact lens); local trauma; exposure | Staph hypersensitivity; peripheral vascular; autoimmune |
| Pain level | Severe, bilateral | Severe, unilateral | Moderate, bilateral |
| Vision threat | β β Both eyes β catastrophic potential | β One eye | Lower (peripheral location) |
| Hypopyon | Possible, one or both eyes | Common with severe bacterial keratitis | Rare |
| Systemic workup indicated | β Always | Selectively (when unusual or refractory) | When autoimmune suspected |
| Correct ICD-10 code | H16.013 | H16.011 (right) / H16.012 (left) | H16.043 |
When H16.013 Is β and Is Not β Appropriate
H16.013 requires that both eyes have documented central corneal ulcers at the same encounter. Do not assign H16.013 simply because a patient has a history of corneal ulcer in one eye and a new ulcer in the other at a later date β assign the appropriate unilateral code for the active eye. Do not assign H16.013 when one eye has a central ulcer (H16.011 or H16.012) and the other has a different type of corneal pathology (e.g., marginal ulcer, keratopathy, or scar from prior ulceration). The bilateral code requires bilateral central corneal ulcers documented as simultaneously active at the same encounter.
β When to Assign H16.013
- Physician or ophthalmologist explicitly documents central corneal ulcer, bilateral or describes active central ulcerative lesions in both eyes simultaneously at the same encounter
- Documentation uses terms such as: bilateral central corneal ulcers, central ulcerative keratitis both eyes, bilateral central keratitis with ulceration, bilateral corneal ulcer β central β OU
- Slit-lamp exam with fluorescein confirms active central epithelial defects with stromal involvement in both eyes at the time of the encounter
- Use H16.013 for both infectious and non-infectious bilateral central ulcers when bilaterality is explicitly documented
β When NOT to Assign H16.013
- Only one eye is currently ulcerated β assign H16.011 (right) or H16.012 (left); do not use the bilateral code when only one eye is actively affected
- Different ulcer types in each eye (e.g., central ulcer right eye + marginal ulcer left eye) β assign the specific code for each eye separately: H16.011 + H16.042
- History of ulcer in one eye, new ulcer in the other at a separate encounter β assign the unilateral code for the active eye; prior ulcer history does not make the current encounter bilateral
- Bilateral corneal ulcers with hypopyon β when hypopyon is explicitly documented in both eyes, consider H16.033 (corneal ulcer with hypopyon, bilateral) as the more specific code
- Bilateral mycotic (fungal) corneal ulcers β assign H16.063 when fungal etiology is confirmed bilaterally
- Bilateral perforated corneal ulcers β assign H16.073 β perforation is a critical code upgrade that must be captured
- Bilateral herpes simplex keratitis β assign B00.52 β the etiology-specific code replaces H16.013 for HSV; note that B00.52 does not have laterality subcodes and covers bilateral involvement
- Bilateral herpes zoster keratitis β assign B02.33
- Bilateral Acanthamoeba keratitis β assign B60.13 (right) and B60.12 (left) as separate codes β no bilateral subcode exists for Acanthamoeba keratitis; assign both laterality-specific codes
- Bilateral exposure keratopathy without frank ulceration β assign H16.203 (bilateral) β exposure keratopathy is distinct from corneal ulceration; upgrade to H16.013 only when frank ulceration is explicitly documented by the clinician
- Stevens-Johnson Syndrome / TEN with corneal involvement β assign the SJS/TEN code (L51.1 / L51.2 / L51.3) as the principal or primary diagnosis with H16.013 as a manifestation; the underlying condition drives the encounter
π³ Code Hierarchy β Corneal Ulcer (H16.0)
ICD-10-CM H16 Keratitis
β
βββ H16.0 Corneal ulcer
β βββ H16.00 Unspecified corneal ulcer
β β βββ H16.001 Unspecified corneal ulcer, right eye
β β βββ H16.002 Unspecified corneal ulcer, left eye
β β βββ H16.003 Unspecified corneal ulcer, bilateral
β β βββ H16.009 Unspecified corneal ulcer, unspecified eye
β β
β βββ H16.01 Central corneal ulcer
β β βββ H16.011 Central corneal ulcer, right eye
β β βββ H16.012 Central corneal ulcer, left eye
β β βββ βΆβΆ H16.013 ββ Central corneal ulcer, bilateral β THIS CODE
β β βββ H16.019 Central corneal ulcer, unspecified eye
β β
β βββ H16.02 Ring corneal ulcer
β β βββ H16.021 Ring corneal ulcer, right eye
β β βββ H16.022 Ring corneal ulcer, left eye
β β βββ H16.023 Ring corneal ulcer, bilateral
β β βββ H16.029 Ring corneal ulcer, unspecified eye
β β
β βββ H16.03 Corneal ulcer with hypopyon
β β βββ H16.031 Corneal ulcer with hypopyon, right eye
β β βββ H16.032 Corneal ulcer with hypopyon, left eye
β β βββ H16.033 Corneal ulcer with hypopyon, bilateral β upgrade when bilateral hypopyon documented
β β βββ H16.039 Corneal ulcer with hypopyon, unspecified eye
β β
β βββ H16.04 Marginal corneal ulcer
β β βββ H16.041 Marginal corneal ulcer, right eye
β β βββ H16.042 Marginal corneal ulcer, left eye
β β βββ H16.043 Marginal corneal ulcer, bilateral
β β βββ H16.049 Marginal corneal ulcer, unspecified eye
β β
β βββ H16.05 Mooren's corneal ulcer
β β βββ H16.051 Mooren's corneal ulcer, right eye
β β βββ H16.052 Mooren's corneal ulcer, left eye
β β βββ H16.053 Mooren's corneal ulcer, bilateral
β β βββ H16.059 Mooren's corneal ulcer, unspecified eye
β β
β βββ H16.06 Mycotic corneal ulcer
β β βββ H16.061 Mycotic corneal ulcer, right eye
β β βββ H16.062 Mycotic corneal ulcer, left eye
β β βββ H16.063 Mycotic corneal ulcer, bilateral β use when fungal etiology confirmed bilaterally
β β βββ H16.069 Mycotic corneal ulcer, unspecified eye
β β
β βββ H16.07 Perforated corneal ulcer
β βββ H16.071 Perforated corneal ulcer, right eye
β βββ H16.072 Perforated corneal ulcer, left eye
β βββ H16.073 Perforated corneal ulcer, bilateral β critical upgrade; do not miss
β βββ H16.079 Perforated corneal ulcer, unspecified eye
β
βββ H16.1-H16.9 Other and unspecified keratitis categories
π Common Secondary Diagnoses & Associated Codes
Acute-Phase Associated Conditions
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| H16.033 | Corneal ulcer with hypopyon, bilateral | β No | When hypopyon is explicitly documented in both eyes β this is the more specific bilateral code; do not assign H16.013 and H16.033 together for the same encounter |
| B00.52 | Herpes simplex keratitis | β No | When HSV is confirmed as the causative organism bilaterally; this etiology-specific code replaces H16.013 β do not assign both |
| H57.13 | Ocular pain, bilateral | β No | Code when bilateral pain is a separately addressed complaint; supports medical necessity documentation |
| H04.123 | Dry eye syndrome, bilateral lacrimal glands | β No | When concurrent bilateral dry eye is documented as contributing to corneal surface breakdown; common in autoimmune and SJS/TEN patients |
| H02.893 | Lagophthalmos, bilateral | β No | When bilateral incomplete lid closure is the documented mechanism of bilateral exposure-related corneal ulceration; code when documented separately by the treating provider |
Systemic Etiology / Risk Factor Codes
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| B20 | Human immunodeficiency virus (HIV) disease | β Yes | HIV-associated immunosuppression is among the most important predisposing conditions for bilateral, severe, or treatment-refractory keratitis; code when documented as active and relevant β also an MCC |
| E11.40 | Type 2 diabetes mellitus with diabetic neuropathy, unspecified | β Yes | Diabetes impairs corneal wound healing and reduces corneal sensitivity, worsening bilateral ulcer severity and healing trajectory; CC |
| M05.79 | Rheumatoid arthritis with rheumatoid factor, multiple sites | β Yes | RA is a recognized cause of bilateral peripheral ulcerative keratitis and may present with central involvement; code the RA when documented as a contributing or causative systemic condition |
| M32.19 | Systemic lupus erythematosus with other organ or system involvement | β Yes | SLE-associated keratitis can present bilaterally; code when documented by the treating clinician as causative or contributing |
| L51.1 | Stevens-Johnson syndrome | β No | SJS causes severe bilateral ocular surface destruction including corneal ulceration; assign as the principal/primary diagnosis when SJS is the driving condition, with H16.013 as a manifestation |
| L51.2 | Toxic epidermal necrolysis | β No | TEN carries even higher mortality and bilateral corneal involvement than SJS; assign as the principal diagnosis with H16.013 coded as a bilateral corneal manifestation |
| G51.0 | Bellβs palsy | β No | Bilateral Bellβs palsy is rare but documented; when bilateral lagophthalmos from CN VII palsy causes bilateral corneal exposure ulceration, code G51.0 as the etiology alongside H16.013 |
Complication / Progression Codes
| ICD-10 Code | Description | Clinical Notes |
|---|---|---|
| H16.073 | Perforated corneal ulcer, bilateral | When bilateral central ulcers progress to bilateral perforation β this is a critical code upgrade; do not assign H16.013 when perforation is documented; assign H16.073 instead |
| H16.063 | Mycotic corneal ulcer, bilateral | When culture confirms fungal etiology bilaterally β upgrade from H16.013 to H16.063 at the encounter when fungal confirmation is documented; do not assign both codes |
| H44.003 | Unspecified purulent endophthalmitis, bilateral | Rare but catastrophic progression when bilateral corneal infection invades the anterior chamber or vitreous; code when separately documented by the treating physician |
| H18.033 | Corneal edema due to contact lens, bilateral | When bilateral contact lens-associated stromal edema is separately documented alongside the ulceration |
Bilateral Coding and Etiology-Specific Codes
When a confirmed infectious etiology is documented bilaterally β HSV (B00.52), herpes zoster (B02.33) β the organism-specific code takes precedence and replaces H16.013. B00.52 does not carry laterality subcodes and is inclusive of bilateral HSV keratitis. For Acanthamoeba, no bilateral-specific code exists β assign B60.13 (right eye) and B60.12 (left eye) together. For bacterial keratitis, no organism-inclusive bilateral code exists β H16.013 remains appropriate with optional B95-B98 organism codes when the pathogen is explicitly documented.
π§ Common CPT Pairings
Diagnostic Studies
| CPT Code | Description | When Used with H16.013 |
|---|---|---|
| 65430 | Scraping of cornea; diagnostic, for smear and/or culture | Performed on both eyes when bilateral ulcers are present; each scraping is separately documented; bilateral procedures billed per eye β confirm payer policy regarding modifier requirements for bilateral corneal procedures |
| 92014 | Ophthalmological services; medical examination and evaluation, comprehensive, established patient | Comprehensive bilateral anterior segment assessment including slit-lamp biomicroscopy of both eyes; this is the appropriate level for most bilateral corneal ulcer presentations |
| 92012 | Ophthalmological services; medical examination and evaluation, intermediate, established patient | Intermediate follow-up visits monitoring bilateral epithelial closure and treatment response |
| 92250 | Fundus photography | When posterior segment evaluation is warranted to exclude bilateral endophthalmitis or assess for posterior pathology in the setting of severe bilateral infection or SJS/TEN |
| 92285 | External ocular photography | Serial photographic documentation of bilateral ulcer size, density, and healing progression; supports medical necessity documentation for ongoing intensive treatment |
Treatment / Therapeutic Procedures
| CPT Code | Description | When Used with H16.013 |
|---|---|---|
| 65600 | Multiple punctures of anterior cornea | Epithelial dΓ©bridement of one or both eyes; performed per eye when bilateral |
| 65710 | Keratoplasty; lamellar (DALK) | When deep bilateral stromal involvement necessitates staged lamellar corneal transplantation; bilateral keratoplasty is performed in staged sequential procedures, not simultaneously |
| 65730 | Keratoplasty; penetrating (PKP) | Full-thickness corneal transplant for bilateral perforated or medically non-responsive central ulcers; typically staged; more commonly paired with H16.073 when perforation drives the surgical indication |
| 67880 | Construction of intermarginal adhesions, median tarsorrhaphy, or canthorrhaphy | When bilateral lagophthalmos is present and temporary bilateral lid closure is used to protect both corneal surfaces during healing; billed per eye |
Bilateral Procedures and Modifier Considerations (Professional Fee Billing)
When corneal procedures are performed on both eyes at the same encounter β such as bilateral corneal scrapings (65430) β professional fee claims must follow payer-specific bilateral billing rules. Many payers require a modifier on the second procedure line when the same CPT code is billed twice for bilateral procedures. The specific modifier required varies by payer contract and payer type (Medicare vs. commercial). Review payer-specific bilateral surgery payment policies before submitting bilateral corneal procedure claims. This guidance applies to the professional fee claim β inpatient facility claims use ICD-10-PCS, not CPT.
π₯ MS-DRG Considerations (Inpatient)
Inpatient Coding Note
Bilateral central corneal ulcer (H16.013) is among the more likely presentations to require inpatient admission within the corneal ulcer code family β precisely because bilateral involvement typically signals an underlying systemic condition (HIV, SJS/TEN, severe autoimmune disease) that requires systemic management beyond topical eye drops alone. Inpatient admission is indicated when bilateral ulcers are accompanied by systemic illness, when IV antifungal or antiviral therapy is required, when bilateral perforation is imminent or has occurred, or when the patient cannot reliably self-administer intensive bilateral topical therapy. When H16.013 is the principal diagnosis, DRG assignment falls in MDC 02 under the acute major eye infections grouping β but the systemic comorbidities driving bilateral presentation are where CC/MCC capture becomes critical.
MS-DRG Assignment β Principal Diagnosis H16.013
| MS-DRG | Title | GMLOS | Key Driver |
|---|---|---|---|
| 121 | Acute Major Eye Infections with CC/MCC | ~3.5 days | Systemic comorbidities common in bilateral ulcer presentations β HIV, diabetes, SJS/TEN, sepsis β frequently qualify as CC/MCC; this DRG is the expected grouping for most true bilateral corneal ulcer admissions |
| 122 | Acute Major Eye Infections without CC/MCC | ~2.1 days | Bilateral ulcer admissions without qualifying CC/MCC secondary diagnoses; less common given the systemic nature of most bilateral presentations |
CC/MCC Capture When H16.013 Is the Principal Diagnosis
Because bilateral central corneal ulcers typically occur in the setting of significant systemic disease, CC/MCC capture opportunities are particularly rich for this code. Query the attending for any undocumented but clinically supported conditions:
Secondary Diagnosis Code CC/MCC Status HIV disease B20 MCC Stevens-Johnson syndrome L51.1 MCC β typically this would be PDx if SJS is the driving admission reason Toxic epidermal necrolysis L51.2 MCC Sepsis (when ocular infection is the systemic source) A41.9 MCC Type 2 diabetes with neuropathy E11.40 CC Rheumatoid arthritis (active) M05.79 CC Protein-calorie malnutrition E43 MCC Dehydration E86.0 CC Note: When SJS (L51.1) or TEN (L51.2) is the reason for admission and bilateral corneal ulceration is a manifestation, the SJS/TEN code is the principal diagnosis and H16.013 moves to secondary β the DRG may shift entirely out of MDC 02 in that scenario. Sequence according to the Uniform Hospital Discharge Data Set (UHDDS) definition of principal diagnosis.
When H16.013 Is a Secondary Diagnosis
When a patient is admitted for SJS, sepsis, HIV-related illness, or another systemic condition and bilateral central corneal ulcers are identified and managed during the stay, H16.013 is coded as a secondary diagnosis per UHDDS guidelines. It must be evaluated, treated, or documented as affecting patient management to be reportable. When the systemic disease is the clear reason for admission, the bilateral corneal ulcer follows as a secondary manifestation code.
π Coding Examples
Example 1 β Emergency Department: Bilateral Contact Lens-Associated Keratitis
Clinical Scenario: A 19-year-old female presents to the ED with bilateral eye pain and vision loss after wearing extended-wear contact lenses continuously for one week during finals. Slit-lamp exam reveals bilateral central epithelial defects with dense stromal infiltrates. The treating physician documents: βBilateral central corneal ulcers, both eyes β contact lens-associated bacterial keratitis. Corneal scrapings performed bilaterally. Initiating fortified tobramycin bilateral. Urgent ophthalmology referral placed.β No hypopyon identified.
| Field | Code | Rationale |
|---|---|---|
| PDx | H16.013 | Central corneal ulcer, bilateral β physician explicitly documents bilateral central involvement; valid, complete, billable code; no further laterality specificity is needed or available |
| SDx | H57.13 | Ocular pain, bilateral β documented bilateral pain separately addressed; supports medical necessity |
Note
Contact lens overwear is the most common identifiable local cause of bilateral central corneal ulcers in otherwise healthy young patients. Once culture results return, no code change to H16.013 is required for bacterial keratitis β an additional B95-B98 organism code may be appended if the treating physician explicitly documents the specific causative organism. If HSV is subsequently confirmed bilaterally, the code shifts to B00.52.
Example 2 β Inpatient: SJS-Associated Bilateral Corneal Ulceration
Clinical Scenario: A 34-year-old male with Stevens-Johnson syndrome (confirmed, triggered by sulfonamide antibiotic) is admitted to the burn unit. Ophthalmology is consulted on day 2 of admission and documents: βBilateral central corneal ulcers, both eyes, secondary to SJS-related ocular surface disease. Symblepharon formation beginning. Initiating bilateral preservative-free lubricants, bandage contact lenses, and amniotic membrane consideration.β The principal diagnosis driving admission is Stevens-Johnson syndrome.
| Field | Code | Rationale |
|---|---|---|
| PDx | L51.1 | Stevens-Johnson syndrome β the reason for admission; SJS is the principal diagnosis; H16.013 is a manifestation of the SJS |
| SDx | H16.013 | Central corneal ulcer, bilateral β documented bilateral corneal manifestation of SJS; managed during the stay; reportable per UHDDS as it affects management |
| SDx | T36.8X5A* | Adverse effect of sulfonamides, initial encounter β when the triggering drug is documented; sequence after the manifestation codes per adverse effect coding guidelines |
Warning
When SJS (L51.1) or TEN (L51.2) is the reason for admission, those codes are sequenced as principal diagnosis β even when the ophthalmologic complication is what prompted the consult. H16.013 in this scenario is a secondary manifestation code, not the principal diagnosis. Sequencing H16.013 as the PDx in an SJS admission would be a significant coding error that misrepresents the reason for admission and may affect DRG assignment.
Example 3 β Inpatient: HIV with Bilateral Refractory Fungal Keratitis
Clinical Scenario: A 44-year-old male with HIV (CD4 85) is admitted after failing bilateral topical antifungal therapy for corneal ulcers. Bilateral corneal cultures confirm Candida albicans. The attending documents: βBilateral mycotic corneal ulcers confirmed β Candida keratitis bilateral. HIV with severe immunosuppression, CD4 85. Admitting for IV micafungin. Right eye more severely involved; risk of right eye perforation.β No perforation documented at admission.
| Field | Code | Rationale |
|---|---|---|
| PDx | H16.063 | Mycotic corneal ulcer, bilateral β confirmed fungal (Candida) etiology bilaterally documented; H16.063 is the appropriate specific code; do not assign H16.013 when the mycotic-specific code is supported by culture and documentation |
| SDx | B20 | HIV disease β MCC; active HIV with CD4 85 directly drives immunosuppression, antifungal treatment failure, and inpatient admission decision |
| MS-DRG | 121 | Acute Major Eye Infections with MCC β B20 (HIV) qualifies as MCC; drives DRG 121 over 122 and significantly increases facility reimbursement |
Tip
This example highlights two critical specificity decisions: (1) when bilateral fungal etiology is confirmed by culture, the code upgrades from H16.013 to H16.063 β the mycotic bilateral-specific code; and (2) B20 (HIV) as an MCC drives DRG 121 over 122. Leaving the claim at H16.013 + DRG 122 when H16.063 + B20 + DRG 121 is clinically and documentarily supported represents both a coding accuracy failure and a revenue integrity risk. Additionally, if right eye perforation develops during the stay, a further code upgrade to H16.073 (perforated bilateral) or separate unilateral perforation codes may be required β query the attending if documentation evolves.
β οΈ Common Coding Pitfalls
-
Using H16.013 when only one eye has a central ulcer: The bilateral code requires both eyes to have documented central corneal ulcers at the same encounter. Assigning H16.013 because the patient has a history of prior ulcer in one eye and a new ulcer in the other β at different encounters β is incorrect. Assign the appropriate unilateral code for the currently active eye.
-
Using H16.013 when different ulcer types affect each eye: If the right eye has a central ulcer (H16.011) and the left eye has a marginal ulcer (H16.042) or any other corneal pathology, assign the specific code for each eye separately. H16.013 is only appropriate when both eyes have central corneal ulcers simultaneously.
-
Failing to upgrade when a more specific bilateral code applies: When the physician documents bilateral hypopyon β assign H16.033; bilateral fungal etiology β assign H16.063; bilateral perforation β assign H16.073. Do not continue coding H16.013 once the clinical picture has evolved to meet criteria for a more specific bilateral code.
-
Using H16.013 for bilateral herpes simplex keratitis: When HSV is the documented etiology, B00.52 is the correct code β it is inclusive of bilateral involvement and does not require separate laterality coding. Assigning H16.013 alongside B00.52 is redundant and incorrect.
-
Missing the systemic workup as a coding opportunity: Bilateral corneal ulcers almost always occur in the context of a significant systemic predisposing condition. Failing to code HIV (B20), SJS/TEN (L51.1 / L51.2), diabetes (E11.40), or rheumatoid arthritis (M05.79) when documented leaves CC/MCC weight on the table and produces an incomplete clinical picture on the claim.
-
Sequencing H16.013 as PDx when SJS or TEN is the reason for admission: In SJS/TEN admissions, the dermatologic-systemic condition (L51.1 / L51.2) is the principal diagnosis. The bilateral corneal ulcer is a secondary manifestation code. Incorrect sequencing misrepresents the reason for admission and may alter DRG assignment.
-
Billing bilateral procedures without payer-specific modifier review: When the same corneal procedure is performed on both eyes at the same encounter (e.g., bilateral corneal scrapings), professional fee billing requires attention to payer-specific bilateral billing rules. Failure to follow payer-specific modifier requirements may result in claim denial or reduced payment. Always confirm the payerβs bilateral surgery policy before submitting.
π Sources
ICD-10-CM Official Guidelines for Coding and Reporting FY2025 Β· CMS ICD-10-CM Tabular List FY2025 Β· CMS MS-DRG Grouper v42.1 (Effective April 1, 2025) β MDC 02, DRG 121/122 Β· CMS-HCC Risk Adjustment Model v28 (2024) Β· AHA Coding Clinic for ICD-10-CM/PCS Β· AAPC ICD-10-CM Code Reference β H16.013 Β· AAPC Codify β ICD-10 H16 Code Category Β· American Academy of Ophthalmology β Preferred Practice Pattern: Bacterial Keratitis (2022 Update) Β· StatPearls β Corneal Ulcer. NCBI Bookshelf, NIH (2024) Β· Cleveland Clinic Health Library β Corneal Ulcer: Causes and Treatment (2023) Β· Medscape β Corneal Ulcer: Background, Etiology, Pathophysiology (2023) Β· AMA CPT 2025 Professional Edition (for CPT pairing codes)
Crystal's MCW Coder Hub